Quinlan Paul T insider trades
Quinlan Paul T has filed 22 Form 4s with the SEC that we hold, for CBAY (General Counsel) and Oruka Therapeutics, Inc. (ORKA) (General Counsel). Across all of them we count 0 purchases worth $0 and 28 sales worth $8.6M reported on Form 4. In the last 12 months: 0 purchases ($0) and 18 sales ($7.5M). The largest single trade was a sale of 14,696 shares of Oruka Therapeutics, Inc. worth $1.6M, dated 2026-08-14. Of 10 sales filed since we began reading the 10b5-1 checkbox, 9 (90%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2022-01-27 and the latest 2026-10-20.
CBAY
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2023-05-15 | S, sale reported on Form 4 | 5,000 | $51.8K | 2023-05-17 | SEC |
| 2023-06-30 | S, sale reported on Form 4 | 5,000 | $50.2K | 2023-06-30 | SEC |
| 2023-07-14 | S, sale reported on Form 4 | 5,000 | $59.0K | 2023-07-14 | SEC |
| 2023-08-15 | S, sale reported on Form 4 | 5,000 | $59.5K | 2023-08-16 | SEC |
| 2023-09-15 | S, sale reported on Form 4 | 24,000 | $404.9K | 2023-09-19 | SEC |
| 2023-09-15 | S, sale reported on Form 4 | 5,000 | $84.3K | 2023-09-19 | SEC |
| 2023-10-16 | S, sale reported on Form 4 | 5,000 | $68.8K | 2023-10-18 | SEC |
| 2023-11-15 | S, sale reported on Form 4 | 5,000 | $86.9K | 2023-11-17 | SEC |
| 2023-12-15 | S, sale reported on Form 4 | 5,000 | $109.9K | 2023-12-15 | SEC |
| 2024-01-16 | S, sale reported on Form 4 | 5,000 | $117.9K | 2024-01-16 | SEC |
Oruka Therapeutics, Inc. (ORKA)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2026-03-16 | S, sale reported on Form 4 | 733 | $30.3K | 2026-03-17 | SEC |
| 2026-06-15 | S, sale reported on Form 4 | 733 | $51.1K | 2026-06-15 | SEC |
| 2026-08-14 | S, sale reported on Form 4 | 3,630 | $385.0K | 2026-08-14 | SEC |
| 2026-08-14 | S, sale reported on Form 4 | 10,434 | $1.1M | 2026-08-14 | SEC |
| 2026-08-14 | S, sale reported on Form 4 | 14,696 | $1.6M | 2026-08-14 | SEC |
| 2026-08-14 | S, sale reported on Form 4 | 10,200 | $1.1M | 2026-08-14 | SEC |
| 2026-08-14 | S, sale reported on Form 4 | 9,193 | $1.0M | 2026-08-14 | SEC |
| 2026-08-14 | S, sale reported on Form 4 | 3,847 | $427.5K | 2026-08-14 | SEC |
| 2026-09-15 | S, sale reported on Form 4 | 1,039 | $99.4K | 2026-09-15 | SEC |
| 2026-09-21 | S, sale reported on Form 4 | 2,900 | $267.9K | 2026-09-21 | SEC |
| 2026-09-21 | S, sale reported on Form 4 | 3,832 | $357.6K | 2026-09-21 | SEC |
| 2026-09-21 | S, sale reported on Form 4 | 601 | $56.8K | 2026-09-21 | SEC |
| 2026-09-21 | S, sale reported on Form 4 | 2,667 | $254.2K | 2026-09-21 | SEC |
| 2026-10-20 | S, sale reported on Form 4 | 400 | $30.0K | 2026-10-20 | SEC |
| 2026-10-20 | S, sale reported on Form 4 | 500 | $38.1K | 2026-10-20 | SEC |
| 2026-10-20 | S, sale reported on Form 4 | 1,000 | $77.2K | 2026-10-20 | SEC |
| 2026-10-20 | S, sale reported on Form 4 | 4,100 | $323.0K | 2026-10-20 | SEC |
| 2026-10-20 | S, sale reported on Form 4 | 3,000 | $238.5K | 2026-10-20 | SEC |
Counted from the Form 4 filings this reporting owner (SEC CIK 1333277) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
